---
title: "JD HEALTH and Pinnacle Bio have reached a cooperation on integrated health management solutions"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273188534.md"
description: "JD HEALTH has reached a deep cooperation with Beijing Dingfeng Biotechnology to jointly create an integrated health management solution that covers screening, diagnosis, treatment, medication, follow-up, and protection. By integrating digital technology and industrial resources, both parties will improve the full-cycle health services and explore sustainable development. JD HEALTH will leverage its advantages in the pharmaceutical supply chain and integrated online and offline services to collaborate deeply with Dingfeng Biotechnology in areas such as drug accessibility, health knowledge dissemination, and patient management"
datetime: "2026-01-21T07:11:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273188534.md)
  - [en](https://longbridge.com/en/news/273188534.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273188534.md)
---

# JD HEALTH and Pinnacle Bio have reached a cooperation on integrated health management solutions

JD Health (06618.HK) announced a deep cooperation with Beijing Dingfeng Biotechnology. The two parties will jointly create an integrated health management solution covering "screening - diagnosis - treatment - medication - follow-up - protection," enhancing the full-cycle health service layout through digital technology empowerment and industrial resource integration, and building a complete service closed loop from preventive intervention, precise screening to standardized diagnosis and treatment, and rehabilitation management.

According to the cooperation agreement, JD Health will leverage its advantages in the pharmaceutical supply chain system, digital user reach capabilities, and integrated online and offline service network to conduct deep collaboration with Dingfeng Biotechnology in areas such as improving drug accessibility, health knowledge popularization, comprehensive patient management, and service model innovation, jointly exploring the sustainable development of full-cycle health management

### Related Stocks

- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [516610.CN](https://longbridge.com/en/quote/516610.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [603334.CN](https://longbridge.com/en/quote/603334.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [01061.HK](https://longbridge.com/en/quote/01061.HK.md)
- [06618.HK](https://longbridge.com/en/quote/06618.HK.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)

## Related News & Research

- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md)
- [Broncus shareholders back all AGM resolutions, update articles of association](https://longbridge.com/en/news/286439966.md)
- [Basecare Wins NMPA Class III Approval for Gems Embryo Culture Medium](https://longbridge.com/en/news/286258287.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)